期刊文献+

盐酸阿齐利特合成工艺的改进

Improved synthesis of Azimilide dihydrochloride
下载PDF
导出
摘要 目的改进盐酸阿齐利特的合成工艺。方法以对氯苯胺为原料合成5-对氯苯基-2-糠醛(Ⅱ);Ⅱ与1-氨基海因盐酸盐(Ⅲ)经缩合反应合成1-[5-(对氯苯基)糠叉氨基]海因(Ⅳ);在DMF中,Ⅳ与1,4-化合物二溴丁烷,再与1-甲基哌嗪反应,经盐酸乙醇成盐制得盐酸阿齐利特(Ⅰ)。结果总收率57.1%,纯度99.5%(HPLC),化合物Ⅰ的结构经1HN-MR、13CNMR、MS确证。结论该方法反应条件温和,操作简便,成本约为原工艺的50%,适合规模化生产。 OBJECTIVE To improve the synthesis method of azimilide dihydrochloride. METHODS Azimilide dihydrochloride ( Ⅰ ) was obtained by one -pot reaction of intermediate 1 - [ 5 - (p -chlorophenyl)furfurylideneamino ] hydantoin ( 1V ) with 1,4 - dibromobutane and 1 - methylpiperazine, then by salt formation. The compound IV was obtained by condensation of 1 - aminohydantoin hydrochloride (Ⅲ) with 5 - p - ehlorophenyl - 2 - furfural ( II ), which were prepared from p - chloro - aniline by diazotization and displacement. RESULTS The total yield is 57.1% ( calculated for p - chloro - aniline), and the purity is 99.5 % (HPLC). The chemical structures of the intermediates and target product have been confirmed with 1HNMR, 13 CNMR, and MS. CONCLUSION The procedure developed has several advantages of convenient operation, lower cost and might be applied to scale manufacture.
出处 《华西药学杂志》 CAS CSCD 北大核心 2009年第1期51-53,共3页 West China Journal of Pharmaceutical Sciences
关键词 盐酸阿齐利特 抗心律失常药物 合成 1 4-二溴丁烷 Azimilide dihydrochloride Antiarrhythmic agent Synthesis 1, 4 - Dibromobutane
  • 相关文献

参考文献6

  • 1张翌,任戎,刘登科,王平保,陈立功.盐酸阿齐利特的合成[J].中国药物化学杂志,2006,16(4):226-228. 被引量:4
  • 2段军,李向平.新型Ⅲ类抗心律失常药物阿齐利特[J].中国新药杂志,2005,14(1):114-117. 被引量:3
  • 3Pratt CM, A1 - Khalidi HR, Brum JM, et al. Cumulative experience of Azimilide - associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database[ J]. J Am College Cardiology, 2006, 48 (3) :471 -477.
  • 4Yu CH, Pelosi JR SS, Calcagno MA. 4 -Oxocyclic ureas useful as antiarrhythmic and antilibrillatory agents [ P ]. US 5462940, 1995-10-31.
  • 5Matson PA, Godlewski MS, Quorroz D, et al. Process for making 1, 3 - disubstituted - 4 - oxocyclic ureas [ P]. WO 9955700, 1999 -11 -04.
  • 6Stewert DC,Snyder JR HR. 1 - (5 - substituted) furfurylideneamino hydantoins and imidazolidinones [P]. US 3415821,1968 - 12 - 10.

二级参考文献21

  • 1段军,李向平.新型Ⅲ类抗心律失常药物阿齐利特[J].中国新药杂志,2005,14(1):114-117. 被引量:3
  • 2Brooks RR,Carpenter JF, Miller KE, et al. Efficacy of the class Ⅲ antiarrhythmic agent azimilide in rodent models of ventricular arrhythmia[J]. Proc Soc Exp Biol Med ,1996 , 212 (1) :84 - 93.
  • 3Pritchett E,Page R, Connolly S, et al. Azimilide treatment of atrial fibrillation[J]. Circulation, 1998,98(Suppl): S633.
  • 4Page RL, Connolly SJ,Wilkinson WE, et al. Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose response[J]. Am Heart J ,2002,143(4) :643 - 649.
  • 5Camm AJ, Karam R, Pratt CM. The azimilide post-infarct survival evaluation (ALIVE) trial [J]. Am J Cardiol, 1998, 81(6A) :35D- 39D.
  • 6Bramah S. Azimilide:a viewpoint by Bramah Singh[J]. Drugs, 2000,59(2) :278 - 279.
  • 7Gintant GA. Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes [ J ]. J Cardiovasc Pharmacol, 1998, 31(1): 945 - 953.
  • 8Delyth C,Anthony M. Azimilide[J]. Drugs,2000,59(2):271 - 277.
  • 9Nattel S,Liu L,St-Georges D. Effects of the novel antiarrhyth mic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties[ J ]. Cardiovasc Res, 1998,37 ( 3 ): 627 - 635.
  • 10Lamorgese M, Kirian M, Van Wagoner DR. Azimilide (NE10064)blocks outward K ^+ currents in human atrial and ventricular myocytes[ J ]. Circulation, 1995,92 (Suppl): 1 - 575.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部